Managers / Q2 2023 · view latest →
Weaver C. Barksdale & Associates, Inc.
CIK 0001294588 · 40 BURTON HILLS BLVD., SUITE 230, NASHVILLE, TN, 37215 · 615-665-1085
Summary
Weaver C. Barksdale & Associates, Inc. reported $101M in U.S.-listed holdings across 62 positions for Q2 2023.
Its largest position, AVGO, represents 2.5% of the portfolio.
The book was largely unchanged from Q1 2023.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 91.0% · $92M
- Other · 4.8% · $5M
- REIT · 4.2% · $4M
Quarter-over-Quarter Changes full breakdown →
vs Q1 2023 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| PFEPFIZER INC | ADDED | +9.0K | 44.5K | +$182,533 | $2M |
| UNILEVER PLC | TRIMMED | −9.8K | 33.6K | −$503,847 | $2M |
| ENBENBRIDGE INC | ADDED | +8.3K | 49.3K | +$267,944 | $2M |
| MRKMERCK & CO INC | TRIMMED | −3.8K | 15.9K | −$262,209 | $2M |
| AVGOBROADCOM INC | TRIMMED | −686 | 2.9K | +$219,728 | $3M |
| PRUPRUDENTIAL FINL INC | ADDED | +2.9K | 21.7K | +$362,591 | $2M |
| JPMJPMORGAN CHASE & CO | ADDED | +1.8K | 13.5K | +$438,864 | $2M |
| SNASNAP ON INC | TRIMMED | −1.1K | 7.7K | +$52,898 | $2M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2023
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $105M | 62 | May 14, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $95M | 62 | Feb 13, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $104M | 62 | Nov 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $104M | 62 | Aug 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $104M | 62 | May 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $104M | 62 | Feb 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $111M | 62 | Nov 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $105M | 62 | Aug 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $109M | 62 | May 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $102M | 62 | Feb 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $117M | 62 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $101M | 62 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $107M | 62 | May 12, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $113M | 62 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $100M | 63 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $107M | 63 | Aug 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $112M | 61 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $110M | 59 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.